Faricimab versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME
Nov 15, 2023, 03:18 PM
Retina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.